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Background: Terminal sedation in patients nearing death is an
important issue related to end-of-life care.
Objective: To describe the practice of terminal sedation in the
Netherlands.
Design: Face-to-face interviews.
Setting: The Netherlands.
Participants: Nationwide stratified sample of 482 physicians;
410 responded and 211 of these reported characteristics of their
most recent terminal sedation case.
Measurements: Physician reports of frequency of terminal se-
dation (defined as the administration of drugs to keep the patient
in deep sedation or coma until death, without giving artificial
nutrition or hydration), characteristics of the decision-making pro-
cess, drugs used, the estimated life-shortening effect, and fre-
quency of euthanasia discussions.
Results: Of respondents, 52% (95% CI, 48% to 57%) had ever
used terminal sedation. Of the 211 most recent cases, physicians
used terminal sedation to alleviate severe pain in 51% of patients
(CI, 44% to 58%), agitation in 38% (CI, 32% to 45%), and
dyspnea in 38% (CI, 32% to 45%). Physicians reported discuss-
ing with patients the decision to use deep sedation in 59% of the
211 most recent cases (CI, 52% to 66%) and the decision to
forgo artificial nutrition or hydration in 34% (CI, 28% to 41%).
Hastening death was partly the intention of the physician in 47%
(CI, 41% to 54%) of cases and the explicit intention in 17% (CI,
13% to 22%) of cases.
Limitations: The generalizability of physician reports about their
most recent cases to all terminal sedation cases is uncertain. In
addition, the findings are subject to recall bias and may not apply
to other geographic settings.
Conclusions: Terminal sedation precedes a substantial number
of deaths in the Netherlands. In about two thirds of most recently
reported cases, physicians indicated that in addition to alleviating
symptoms, they intended to hasten death.
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Patients nearing death frequently have symptoms such asdyspnea, agitation, pain, and anxiety (1, 2). One of the
most important goals of the medical care provided to these
patients is the alleviation of these symptoms (3). If treat-
ment with analgesic or anxiolytic agents is not effective,
sedatives are sometimes used as an alternative to render
patients unconscious and then oblivious to their symptoms
(4, 5). Subsequently, if artificial nutrition and hydration
are not given, death will follow soon.
The ethical debate about this practice focuses on the
extent to which it should be considered an end-of-life de-
cision that possibly or certainly hastens death. Previous
studies have explored the differences and similarities with
other end-of-life decisions, such as euthanasia and physi-
cian-assisted suicide (6–19). However, little information
exists on the medical practice of deep sedation with the
forgoing of artificial nutrition or hydration in patients
nearing death. Estimates about the frequency of deep seda-
tion at the end of life vary from 15% to more than 60%,
depending on the settings studied and the definitions used
(4, 5, 20–26). The terminology used reflects these differ-
ences in definition of the practice of deep sedation at the
end of life. Although “terminal sedation” is the most com-
monly used term, other frequently used terms, which dem-
onstrate the different perspectives from which this practice
is viewed, are “sedation for intractable distress in the im-
minently dying,” “palliative sedation therapy,” “slow eu-
thanasia,” “opioid coma,” or “anesthetic coma” (6, 27–30).
The present study describes the practice of terminal
sedation in the Netherlands. This study was part of the
evaluation of the notification procedure for physician-
assisted death in the Netherlands, which was commis-
sioned by the ministers of Health and Justice (31).
METHODS
Respondent Characteristics
We interviewed a nationwide sample of 410 physi-
cians: 208 clinical specialists, 125 general practitioners, and
77 nursing home physicians. In the Netherlands, clinical
specialists provide hospital care, general practitioners pro-
vide nonspecialized care outside the hospital, and nursing
home physicians work in long-term care institutions
mainly for elderly people. The proportions of deaths in
these health care settings are approximately 35%, 42%,
and 23%, respectively. The specialties involved in our
study covered about 95% of all deaths in the Netherlands
in 2001. The respondents were selected according to the
following criteria: They were required to be in active prac-
tice at the time of the interview and to have actively prac-
ticed medicine within the registered specialty for the past 2
years in the same setting. All addresses were taken from the
professional registries of the relevant specialties. To arrive
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at the desired number of 410 physicians, we sampled 482
physicians. Seventy-two physicians (15%) declined to take
part in the study: 17% of clinical specialists, 18% of gen-
eral practitioners, and 3% of nursing home physicians.
Nonresponders did not differ in age from responders.
Face-to-face interviews were conducted by experienced
part-time working or recently retired physicians who were
trained to administer the structured questionnaires. All in-
terviews took place between March 2002 and October
2002. We applied strict rules to ensure the anonymity of
all physicians and patients studied.
Interview Process
The interview schedule addressed experiences with
end-of-life decision making (Appendix Figure [Question-
naire on Terminal Sedation], available at www.annals.org).
Terminal sedation was defined as the administration of
drugs to keep the patient in deep sedation or coma until
death, without giving artificial nutrition or hydration. The
respondents were first asked whether they had ever used
terminal sedation and, subsequently, how often they had
performed this practice in 2000 and 2001. Additional
questions about the practice of terminal sedation con-
cerned the physician’s most recent patient to have received
terminal sedation (n  211). The physicians were asked
about the patient’s characteristics; whether or not sedation
or the forgoing of artificial nutrition or hydration had been
discussed with the patient, family, or other health care
professionals; the drugs used; the intention of the physi-
cian; the estimated life-shortening effect; and whether eu-
thanasia was discussed during the decision process.
Statistical Analysis
We calculated all estimates about the occurrence of
terminal sedation in the Netherlands by weighting the es-
timates of individual physicians. Weighting factors were
based on differences in sampling fractions and response
rates for the different specialties. These sampling fractions
were 125 of 7027 for general practitioners, 77 of 810 for
nursing home physicians, 34 of 394 for cardiologists, 34 of
545 for neurologists, 69 of 1321 for specialists in internal
medicine, 35 of 325 for pulmonologists, and 36 of 769 for
surgeons. The probabilities used to determine sampling
weights were 1 in 56 for general practitioners, 1 in 11 for
nursing home physicians, 1 in 12 for cardiologists, 1 in 16
for neurologists, 1 in 19 for specialists in internal medicine,
1 in 9 for pulmonologists, and 1 in 21 for surgeons.
Data on the 211 most recent patients seen by physi-
cians were not weighted. All analyses were done by using
SPSS software, version 10.0 (SPSS, Inc., Chicago, Illinois).
Role of the Funding Sources
The sponsors approved the study design but were not
involved in the collection, analysis, or interpretation of the
data or in the decision to submit the manuscript for pub-
lication.
RESULTS
Most of the 410 physicians interviewed (76%) were
men; 51% were clinical specialists, 30% were general prac-
titioners, and 19% were nursing home physicians (Tables
1 and 2). Of all physicians, a weighted percentage of 52%
(95% CI, 48% to 57%) had ever practiced terminal seda-
tion. This percentage was 55% (CI, 49% to 62%) for
clinical specialists, 48% (CI, 39% to 57%) for general
practitioners, and 75% (CI, 64% to 83%) for nursing
home physicians. We asked all interviewed physicians to
estimate the total number of times they performed termi-
nal sedation in 2000 and 2001. These numbers were ex-
trapolated to the total number of 140 377 deaths in 2001
by multiplying them with the weighting factor for each
specialty and assuming that the numbers were similar for
the 5% of deaths covered by hospital doctors from special-
ties other than the ones included in our study. This extrap-
Table 1. Characteristics of Interviewed Physicians
Variable Physicians
(n  410), %
Sex
Male 76
Female 24
Age
30–44 y 35
45–54 y 45
55 y 20
Specialty
Clinical specialist 51
General practitioner 30
Nursing home physician 19
Context
Terminal sedation, the administration of sedating medica-
tions with cessation of nutrition and hydration, is an op-
tion for care of patients who are nearing death. However,
little is known about physician’s experience with terminal
sedation.
Contribution
Of more than 400 physicians in the Netherlands who
completed a survey about end-of-life care, just over half
had ever used terminal sedation. Common reasons for us-
ing terminal sedation were relief of pain, agitation, or dys-
pnea. Hastening death was the primary intention in only
17% of reported cases.
Caution
Because attitudes and practices regarding terminal seda-
tion vary geographically and culturally, it is unclear
whether these results are generalizable outside of the
Netherlands.
–The Editors
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olation suggests that physicians used terminal sedation in
10.0% (CI, 9.1% to 10.8%) of all deaths in that year. Of
the 10.0% of deaths preceded by terminal sedation, 5.5%
(CI, 5.0% to 6.1%) were attended by clinical specialists,
2.5% (CI, 1.9% to 3.2%) by general practitioners, and
2.0% (CI, 1.7% to 2.2%) by nursing home physicians.
Of all physicians who had ever used terminal sedation,
211 provided information about their most recent cases of
terminal sedation (103 clinical specialists, 53 general prac-
titioners, and 55 nursing home physicians). Of these most
recent cases, 78% (CI, 72% to 83%) involved patients 65
years of age or older and 54% (CI, 47% to 60%) involved
patients who had cancer (Table 3). Clinical specialists and
nursing home physicians also frequently reported practic-
ing terminal sedation in patients with cardiovascular dis-
eases. The most frequently mentioned reasons for using
terminal sedation were the alleviation of pain (51% [CI,
44% to 58%]), agitation (38% [CI, 32% to 45%]), dys-
pnea (38% [CI, 32% to 45%]), and anxiety (11% [CI, 8%
to 16%]).
In 59% (CI, 52% to 66%) of the most recent cases
seen by physicians, the physician had discussed the seda-
tion with the patient (Table 4); in 33% (CI, 27% to 39%)
of the cases, the patient had requested deep sedation. The
main reasons for not discussing deep sedation with the
patient were the fact that the patient was incompetent or
subcomatose (25% [CI, 20% to 31%]). The decision to
forgo artificial nutrition or hydration was discussed less
frequently with the patient; the respondents reported dis-
cussing this topic in 34% (CI, 28% to 41%) of their most
recent cases and receiving a request from the patient to
forgo artificial nutrition or hydration in 9% (CI, 6% to
13%). Next to patient incompetence (37% [CI, 31% to
44%]), another frequently mentioned reason for not dis-
cussing the decision to forgo artificial nutrition or hydra-
tion was that many physicians perceived this not as op-
tional but rather as a given; they considered terminal
sedation to preclude the concomitant use of artificial nu-
trition and hydration (23% [CI, 18% to 29%]) (data not
shown).
The decision to use sedation was discussed with rela-
tives of the patient in 93% (CI, 89% to 96%) of the most
recent cases seen by physicians, and the decision to forgo
artificial nutrition or hydration was discussed with relatives
in 73% (CI, 67% to 79%) of the most recent cases. The
physicians had discussed the sedation with other caregivers
in 79% (CI, 73% to 84%) of cases and had discussed
forgoing artificial nutrition or hydration in 67% (CI, 60%
to 73%) of cases. Clinical specialists, nursing home physi-
cians, and general practitioners discussed the sedation with
other physicians in 76% (CI, 67% to 83%), 38% (CI,
26% to 52%), and 29% (CI, 18% to 42%) of their most
recent cases, respectively. Nurses were often involved in the
decision making by clinical specialists and nursing home
physicians. Specialists in palliative care from other institu-
tions were rarely consulted. In 17% (CI, 12% to 22%) of
the physicians’ most recent cases, neither the sedation nor
the forgoing of artificial nutrition or hydration was dis-
cussed with other caregivers, and in 1% (CI, 0% to 4%) of
the cases, these decisions were not discussed with the pa-
tient, the relatives, or other caregivers (data not shown).
Most physicians recalled having administered benzodi-
azepines in their most recent cases of terminal sedation.
Twenty-one percent (CI, 16% to 27%) of physicians used
only these drugs; 35% (CI, 29% to 42%) combined ben-
zodiazepines with morphine, and 4% (CI, 2% to 8%)
combined benzodiazepines with another drug (Table 5). In
the remaining cases, physicians mostly used morphine. No
physicians used barbiturates. General practitioners and
nursing home physicians reported using benzodiazepines
relatively frequently, which is in contrast to the clinical
specialists, who were more likely to administer morphine
only.
Of all physicians, 36% (CI, 29% to 42%) reported
having made their most recent decision to perform termi-
nal sedation without the intention of hastening death. The
Table 2. Proportion of Deaths per Specialty*
Specialty Deaths
(n  140 377), %
Clinical specialist 35
General practitioner 42
Nursing home physician 23
* From Statistics Netherlands; Central Death Registry 2001 (32).
Table 3. Characteristics of the Sample Consisting of Each
Physician’s Most Recent Case of Terminal Sedation*
Variable Sample Consisting
of Physician’s Most
Recent Case
(n  211), n (%)
All Deaths in
the Netherlands
in 2001, %
Sex
Male 99 (47) 49
Female 112 (53) 51
Age†
0–64 y 46 (22) 20
65–79 y 88 (42) 35
80 y 76 (36) 46
Main diagnosis
Cancer 113 (54) 27
Cardiovascular diseases 51 (24) 25
Pulmonary diseases 14 (7) 10
Nervous system diseases 17 (8) 11
Other 16 (8) 27
Reason for deep sedation‡
Pain 108 (51) NA
Agitation 80 (38) NA
Dyspnea 80 (38) NA
Anxiety 24 (11) NA
Other 62 (29) NA
* NA  not available.
† In 1 case, information on age was missing.
‡ One or more answers are possible.
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physicians partly had the intention to hasten death in 47%
(CI, 41% to 54%) of cases and had the explicit intention
to hasten death in 17% (CI, 13% to 22%) of cases. This
explicit intention involved only the sedation in 2% (CI,
1% to 5%) of the physicians’ most recent cases, only the
forgoing of artificial nutrition or hydration in 14% (CI,
10% to 19%) of cases, and both sedation and the forgoing
of artificial nutrition or hydration in 1% (CI, 0% to 4%)
of cases.
Of the physicians reporting a recent case, 40% (CI,
34% to 45%) estimated that the patient’s life had been
shortened by 24 hours or less. In 27% (CI, 21% to 33%)
of the cases, life was estimated to have been shortened by
more than 1 week.
Thirty-seven percent (CI, 30% to 43%) of physicians
discussed the option of euthanasia with the patient during
the decision-making process. The main reasons for decid-
ing against euthanasia were as follows: The patient pre-
ferred terminal sedation (9% [CI, 5% to 14%]); the pa-
tient did not explicitly request euthanasia (8% [CI, 5% to
12%]); and the patient viewed terminal sedation as less
disturbing to the natural process of dying than euthanasia
(4% [CI, 2% to 8%]).
DISCUSSION
Terminal sedation is frequently used in end-of-life care
in the Netherlands. Half of all physicians have practiced
terminal sedation. Our study shows that terminal sedation
preceded an estimated 10% (CI, 9% to 11%) of all deaths
in the Netherlands. Another recent Dutch study with a
different study design estimated the incidence of terminal
sedation to be 4% of all deaths (31). These percentages are
lower than the previously reported percentages of 15% to
60% (4, 5, 20–24, 26). This difference is probably ex-
plained in part by the fact that the incidences found in
most other studies do not refer to all deaths in a population
but rather to deaths in a selected inpatient care setting,
such as a hospital or a hospice (4, 5, 20, 22–25). Another
factor that may explain the higher rates of terminal seda-
tion in other studies is our very specific definition of terminal
sedation: Patients had to be deeply sedated or comatose, and
Table 4. Discussion about Deep Sedation and Forgoing Artificial Nutrition or Hydration in Each Physician’s Most Recent Case of
Terminal Sedation, by Physician Specialty
Topic of Discussion Cases Seen by Clinical
Specialists (n  103),
n (%)
Cases Seen by General
Practitioners (n  53),
n (%)
Cases Seen by Nursing
Home Physicians (n  55),
n (%)
Cases Seen by All
Physicians (n  211),
n (%)
Deep sedation
Discussed with patient 67 (65) 28 (53) 30 (55) 125 (59)
Requested by patient 36 (35) 19 (36) 14 (25) 69 (33)
Reason for not discussing*
Patient was incompetent or subcomatose 27 (26) 13 (25) 13 (24) 53 (25)
Deep sedation was clearly in the best
interest of the patient
4 (4) 4 (8) 6 (11) 14 (7)
Patient had dementia 2 (2) 1 (2) 12 (22) 15 (7)
Discussion would have done more harm
than good
0 (0) 1 (2) 1 (2) 2 (1)
Other reason 5 (5) 5 (9) 3 (5) 13 (6)
Discussed with relatives† 94 (91) 48 (92) 53 (96) 195 (93)
Discussed with other caregivers*† 91 (88) 30 (57) 46 (84) 167 (79)
Another physician 78 (76) 15 (29) 21 (38) 114 (54)
Nurses 70 (68) 14 (27) 41 (75) 125 (60)
Specialists in palliative care from other
institutions
3 (3) 5 (10) 0 (0) 8 (4)
Multidisciplinary pain management team 8 (8) 2 (4) 0 (0) 10 (5)
Other 4 (4) 6 (12) 4 (7) 14 (7)
Forgoing artificial nutrition or hydration
Discussed with patient‡ 33 (33) 14 (27) 23 (43) 70 (34)
Requested by patient‡ 9 (9) 3 (6) 6 (11) 18 (9)
Discussed with relatives‡ 68 (67) 34 (65) 49 (91) 151 (73)
Discussed with other caregivers*§ 76 (75) 20 (38) 43 (80) 139 (67)
Another physician 58 (57) 10 (19) 14 (26) 82 (39)
Nurses 60 (59) 11 (21) 41 (76) 112 (54)
Specialists in palliative care from other
institutions
3 (3) 1 (2) 0 (0) 4 (2)
Multidisciplinary pain management team 4 (4) 1 (2) 0 (0) 5 (2)
Other 1 (1) 4 (8) 4 (7) 9 (4)
* One or more answers are possible.
† In 1 case, information was missing.
‡ In 4 cases, information was missing.
§ In 3 cases, information was missing.
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patients receiving artificial nutrition and hydration were ex-
cluded. Other studies used less restrictive definitions. Some
included moderately sedated patients, some included a major-
ity of patients who were sedated intermittently, and none ex-
cluded patients receiving artificial nutrition and hydration (4,
5, 20–24, 26).
Clinical specialists performed half of all cases of termi-
nal sedation, although they attended 35% of the total
number of deaths in the Netherlands. Apparently, terminal
sedation is more often practiced in a hospital than at home.
This may be explained in part by the fact that in-hospital
patients (especially those with cancer or cardiovascular dis-
ease) more often have severe symptoms or extreme exacer-
bations of conditions.
The sample of physicians’ most recent cases of termi-
nal sedation included about equal proportions of both
sexes. Approximately one third of all deaths resulting from
terminal sedation were in patients 80 years of age or older,
whereas 46% of all deaths in the general population oc-
curred in this age group (33). The major reasons for using
terminal sedation were to alleviate severe pain, agitation,
dyspnea, and anxiety. In a review of 17 studies that ad-
Table 5. Drugs Used, Intention of the Physician, Estimated Shortening of Life, and Discussion about Euthanasia in Each Physician’s
Most Recent Case of Terminal Sedation, by Physician Specialty
Variable Clinical Specialists
(n  103), n (%)
General Practitioners
(n  53), n (%)
Nursing Home Physicians
(n  55), n (%)
All Physicians
(n  211), n (%)
Drugs used*
Only benzodiazepines 12 (12) 14 (26) 19 (35) 45 (21)
Benzodiazepines in combination with
morphine or morphine
derivatives†
35 (34) 17 (32) 22 (40) 74 (35)
Benzodiazepines in combination with
other drugs (excluding morphine
or morphine derivatives)
2 (2) 7 (13) 0 (0) 9 (4)
Only morphine or morphine
derivatives
44 (43) 10 (19) 12 (22) 66 (31)
Morphine or morphine derivatives in
combination with other drugs
(excluding benzodiazepines)
4 (4) 4 (8) 2 (4) 10 (5)
All other drugs or combinations 5 (5) 1 (2) 0 (0) 6 (3)
Terminal sedation used‡
Without the intention of hastening
death§
35 (34) 17 (32) 23 (42) 75 (36)
Partly with the intention of
hastening death§
51 (50) 25 (47) 24 (44) 100 (47)
With the explicit intention of
hastening death§
17 (17) 11 (21) 8 (15) 36 (17)
Explicit intention concerned§
Sedation 3 (3) 1 (2) 0 (0) 4 (2)
Forgoing artificial nutrition or
hydration
14 (14) 7 (13) 8 (15) 29 (14)
Both sedation and forgoing
artificial nutrition or hydration
0 (0) 3 (6) 0 (0) 3 (1)
Estimated shortening of life
No shortening or 24 h 36 (36) 23 (44) 22 (42) 81 (40)
1–7 d 40 (40) 16 (31) 11 (21) 67 (33)
1–4 wk 19 (19) 11 (21) 14 (27) 44 (21)
1 mo 6 (6) 2 (4) 5 (10) 13 (6)
Euthanasia discussed¶ 26 (25) 35 (66) 16 (29) 77 (37)
Reasons euthanasia was not
performed
Wish of the patient 4 (4) 11 (21) 4 (7) 19 (9)
No explicit patient request 5 (5) 8 (15) 3 (5) 16 (8)
Terminal sedation is palliative care,
part of natural process of dying
6 (6) 3 (6) 0 (0) 9 (4)
No legal framework 3 (3) 3 (6) 0 (0) 6 (3)
Rapid dying process 1 (1) 3 (6) 2 (4) 6 (3)
Unknown/other 8 (8) 7 (13) 7 (13) 22 (10)
* In 1 case, information on drugs used was missing.
† Possibly combined with other drugs.
‡ Forgoing artificial nutrition or hydration concerned the intention of “hastening death” or “not to prolong life.”
§ Intention concerned either sedation or forgoing artificial nutrition or hydration.
 In 6 cases, information on estimated shortening of life was missing.
¶ In 1 case, information on whether euthanasia was discussed was missing.
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dressed the use of sedatives in the care of patients with
cancer who were in the final stages of life, a syndrome of
delirium and agitation was the most frequently mentioned
indication for sedative use; pain was a much less common
reason for sedation (21). However, most of these studies
did not take into account the use of opioids. In addition,
patients in some of these studies were only moderately
sedated.
In our study, terminal sedation was performed with
benzodiazepines in 60% of the most recent cases seen by
physicians and with morphine or morphine derivatives in
the remaining most recent cases seen. Other studies also
found that benzodiazepines were most commonly used for
deep sedation in patients nearing death. The use of opioids
alone for deep sedation is regarded as less effective than the
use of sedatives and may even be counterproductive (8, 21,
22). Cherny and Portenoy have produced guidelines for
the use of sedation for controlling symptoms; in their opin-
ion, benzodiazepines are the most favored class of sedatives
in palliative care worldwide (34). Some researchers suggest
that opioid use for relief of pain and other symptoms
should be continued when sedation is being instituted to
avoid the possibility of unobservable pain or symptoms of
opioid withdrawal (8). Opioids are frequently used in hos-
pital settings to treat pain and other symptoms. The relatively
high proportion of morphine-induced cases of terminal seda-
tion in our study may indicate that unconsciousness was a
consequence of pain and symptom management or of pro-
gression of the underlying disease.
In our study, terminal sedation was almost always dis-
cussed with relatives but not always with the patient, who
was often no longer communicative. A remarkable finding
was that general practitioners were much less likely to con-
sult other physicians or caregivers. In addition, the physi-
cians in our study rarely consulted specialists in palliative
care from other institutions and rarely consulted pain man-
agement teams. General practitioners were less likely to
involve nurses in decision making about terminal sedation
than were other physicians. This may reflect the fact that
nurses are less available to general practitioners than to
physicians working in institutional settings.
If life-sustaining treatment, such as artificial nutrition
or hydration, is forgone in patients nearing death, death
will usually occur within a short time. However, in our
study, 36% (CI, 29% to 42%) of the physicians made their
most recent decision to perform terminal sedation without
the intention of hastening death. The physicians partly had
the intention to hasten death in 47% (CI, 41% to 54%) of
cases and the explicit intention to hasten death in 17%
(CI, 13% to 22%) of cases. In most reported cases, this
explicit intention concerned the decision not to give arti-
ficial nutrition or hydration. The estimated shortening of
life was limited to less than 1 week in 73% (CI, 67% to
79%) of the cases most recently seen by physicians, indi-
cating that the practice of terminal sedation is not re-
stricted to patients for whom death was imminent.
When making the decision to perform terminal seda-
tion, the physician may have considered euthanasia, that is,
the administration of drugs with the explicit intention to
end life at the patient’s request. The Dutch euthanasia law
was enacted in 2002, but from the early 1990s, physicians
who met the official criteria for prudent practice were not
prosecuted for performing euthanasia. Euthanasia was dis-
cussed in the course of the decision-making process in
about 40% of the cases. Physicians reported that the main
reasons for choosing terminal sedation rather than eutha-
nasia were the patient’s preference for terminal sedation to
euthanasia and the patient’s belief that terminal sedation
was less intrusive than euthanasia on the natural dying
process. In some cases, the physicians reported that eutha-
nasia could not be performed because the patient did not
fulfill the requirements (for example, an explicit patient
request for euthanasia) of prudent practice for euthanasia.
In general, there was a lack of explicit request when the
patient was incompetent or moribund.
In the Dutch context, there are some obvious ethical
and practical differences between terminal sedation and eu-
thanasia. By definition, euthanasia is the result of an ex-
plicit request of the patient. Such a request is not necessary
for terminal sedation. However, the presence (33% in our
study) or absence of a patient’s request or at least discus-
sion with the patient (59% in our study) can be important
in the justification of terminal sedation. With euthanasia,
patients die as a result of the administration of lethal drugs.
By contrast, with terminal sedation, patients die naturally
as a result of their disease (this is most likely when death
occurs in a few days), as a result of forgoing artificial nu-
trition or hydration (when death occurs after more than a
few days), or as a result of the administration of sedatives.
In addition, physicians always use euthanasia with the ex-
plicit intention of hastening death, whereas hastening
death is the primary intent in only a fraction of terminal
sedation cases. Researchers have shown that approximately
2.6% of all deaths in the Netherlands are preceded by
euthanasia; 20% are preceded by the alleviation of pain or
symptoms; and 20% are preceded by decisions to withhold
or withdraw potentially life-prolonging treatments (33).
Cases of terminal sedation in which hastening of death was
not intended or taken into account cannot be considered
to represent either of these end-of-life decisions. When
physicians prescribe sedatives with the explicit intention of
hastening death, their actions may be regarded as inten-
tional ending of life.
Our study has several limitations. First, face-to-face
interviews may be biased by interviewer interpretation.
Moreover, the respondents may have felt obligated to give
socially acceptable answers. We attempted to eliminate
these biases by carefully selecting and training the inter-
viewers and by ensuring strict anonymity of the respon-
dents. Second, the respondents may have had difficulty
recalling the patient’s characteristics; however, recall bias
was probably limited because most cases involved patients
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who died during the preceding 2 years. Third, the term
“terminal sedation” can evoke different connotations and
interpretations in respondents. We tried to avoid this prob-
lem by providing a very specific definition of the term.
Last, our findings may not be generalizable to other coun-
tries because of the openness in Dutch society about end-
of-life issues.
We conclude that terminal sedation precedes a sub-
stantial number of deaths in the Netherlands. Terminal
sedation is an option that is used to alleviate severe symp-
toms in the last phase of life; in most cases, it shortens life
to less than 1 week. According to our reports about physi-
cians’ most recent cases, terminal sedation is usually pro-
vided after discussion with the patient, relatives, and care-
givers. In a limited number of cases, when the physician
administers a sedative with the explicit intention to hasten
death at the explicit request of the patient, terminal seda-
tion seems to approximate the practice of euthanasia.
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2004 PERSONAE PHOTOGRAPHY PRIZE
Annals of Internal Medicine is offering a $500 prize for the best photograph
submitted to Annals in 2004. In an effort to bring people to the pages of the
Annals, the editors began publishing a section called Personae in 1999.
Personae photographs are black and white photographs of people that ap-
peared in the body of the journal from 1999 to 2000 and have appeared on
the cover since 2000. Photographs submitted between 1 January 2004 and 31
December 2004 will be eligible for the prize. Employees of the American
College of Physicians and their family members are not eligible for the prize
but are welcome to submit photographs to be considered for publication.
We are looking for photographs that catch people in the context of their
lives and that capture personality. Annals will publish photographs in black
and white, and black-and-white submissions are preferred. The quality of
photos and their suitability for the vertical space on the cover weigh heavily
in publication decisions. We will also accept color submissions, but any
publication decision will depend on the quality of the photograph after
conversion to black and white. We prefer print submissions, but will accept
slides or digital files. However, photographers may ultimately need to supply
prints of photographs accepted for publication. Photographers should submit
two copies of each print submission. We will not be able to return photo-
graphs, regardless of publication decision. Photographers should not submit
their only copies of photographs.
We must receive written permission to publish the photograph from the
subject (or subjects) of the photograph or the subject’s guardian or next of
kin. Occasionally, we can publish a photograph without the subject’s permis-
sion under the following circumstances: 1) the subject is unidentifiable in the
photograph, or 2) the photograph was taken in a public venue, is not poten-
tially damaging to the subject, and is accompanied by a written statement
from the photographer assuring that the photograph was taken in a public
venue with the subject’s consent. A cover letter assuring no prior publication
of the photograph and providing permission from the photographer for Annals
to publish the image should accompany all submissions. The letter should
also contain the photographer’s name, academic degrees, institutional affili-
ation, mailing address, and telephone and fax numbers. Photographers must
sign over copyright permission to the American College of Physicians before
publication. Photographers who do not find copyright assignment acceptable
should refrain from submitting photographs for consideration.
Please submit photographs or questions to Christine Laine, MD, MPH,
Senior Deputy Editor, Annals of Internal Medicine, 190 N. Independence Mall
West, Philadelphia, PA 19106-1572, claine@acponline.org. We look forward
to receiving your photographs.
ArticleTerminal Sedation in the Netherlands
www.annals.org 3 August 2004 Annals of Internal Medicine Volume 141 • Number 3 185
Current Author Addresses: Drs. Rietjens, van der Heide, Vrakking, and
van der Maas: Department of Public Health, Erasmus MC, PO Box
1738, 3000 DR Rotterdam, the Netherlands.
Drs. Onwuteaka-Philipsen and van der Wal: Department of Social Med-
icine, Vrije Universiteit Medical Center, van der Boechorststraat 7, 1081
BT Amsterdam, the Netherlands.
Author Contributions: Conception and design: J.A.C. Rietjens, A. van
der Heide, A.M. Vrakking, B.D. Onwuteaka-Philipsen, P.J. van der
Maas, G. van der Wal.
Analysis and interpretation of the data: J.A.C. Rietjens, A. van der
Heide, A.M. Vrakking, B.D. Onwuteaka-Philipsen, P.J. van der Maas,
G. van der Wal.
Drafting of the article: J.A.C. Rietjens, A. van der Heide.
Critical revision of the article for important intellectual content: J.A.C.
Rietjens, A. van der Heide, A.M. Vrakking, B.D. Onwuteaka-Philipsen,
P.J. van der Maas, G. van der Wal.
Final approval of the article: J.A.C. Rietjens, A. van der Heide, A.M.
Vrakking, B.D. Onwuteaka-Philipsen, P.J. van der Maas, G. van der
Wal.
Statistical expertise: J.A.C. Rietjens, A. van der Heide.
Obtaining of funding: A. van der Heide, B.D. Onwuteaka-Philipsen,
P.J. van der Maas, G. van der Wal.
Administrative, technical, or logistic support: J.A.C. Rietjens.
Collection and assembly of data: J.A.C. Rietjens.
www.annals.org 3 August 2004 Annals of Internal Medicine Volume 141 • Number 3 W-27
Appendix Figure. Terminal sedation: frequencies and case characteristics.
Throughout the questionnaire, phrases indicate that the respondent should be allowed to look at a particular card. Some questions include the use of
cards with the possible answers for a particular question. The respondent can read the possible answers from the card and then choose the corresponding
answer. ALS amyotrophic lateral sclerosis; COPD chronic obstructive pulmonary disease; CVD cardiovascular disease; MS multiple sclerosis.
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